Afflicting ~31 million people in the United States alone, sinusitis remains one of the most common infections of the upper respiratory tract system, which is observed in children as well as adults, worldwide. People with allergies, asthma, and nasal polyps are more likely to develop sinusitis. Many people with asthma also have chronic sinusitis. People with deficient immune systems, such as those with HIV, are more likely to have sinus problems. Americans spend ~$1 billion each year on over-the-counter medications for the treatment of sinusitis, as indicated by recent research.
Heavy R&D Investments for Receiving Regulatory Approvals
The U.S. Food and Drug Administration approved Dupixent (dupilumab) for the treatment of adults with nasal polyps (growths on the inner lining of the sinuses), accompanied by chronic rhinosinusitis (prolonged inflammation of the sinuses and nasal cavity). This is the first treatment approved for inadequately controlled chronic rhinosinusis with nasal polyps.
Get Sample Copy of this report @ https://www.xploremr.com/connectus/sample/4007
Expanding Patient Pool owing to Associated Risk Factors
Other risk factors related to sinusitis are also expected to increase the demand for better treatment options for acute and chronic sinusitis and other disorders, and this is another factor that is expected to boost the growth of the sinusitis market. FDA observed that sinusitis and asthma often coexist in the same patient. Perhaps 40% to 70% of those with asthma also have sinusitis. These other risk factors related to sinusitis are the increasing patient pool seeking treatment, which is expected to propel the growth of the sinusitis treatment market.
Sinusitis Treatment Market Forecast
Based on the route of administration, the sinusitis treatment market is classified as oral, nasal, topical, and injectable. With a wide range of drug classes in the sinusitis treatment market, such as OTC and prescription drugs, the distribution channel segment of the sinusitis treatment market is further segmented into hospital pharmacies, retail pharmacies, specialty clinics, and online pharmacies. Increase in the patient pool in China, India, as well as an increase in the prevalence of sinusitis in North America make these regions among the fastest-growing sinusitis treatment markets. Furthermore, rigorous research and development activities and increase in the number of factors that are predisposing people to sinusitis are also estimated to offer significant revenue-generating opportunities for the sinusitis treatment market during the forecast period.
Request for Check Discount @ https://www.xploremr.com/connectus/check-discount/4007
Global Sinusitis Treatment Market: Competitive Landscape
This section of the sinusitis treatment market report features the profiles of the key players operating in the sinusitis treatment market based on their marketing and differential strategies.
Examples of some of the key players featured in this report are
- Sanofi, Bayer AG
- Abbott Laboratories
- Eli Lily and company
- Merck & Co, Inc.
- AstraZeneca Plc
- Dr. Reddy’s Laboratories Ltd
- Novartis AG
- Sun Pharmaceuticals
- Pfizer Inc.
Key players in the sinusitis treatment market are keen on upgrading their existing service portfolio and strategies to meet not only service demand, but also dominate the regional market. Many regional & international collaborations between developed and developing nations around the world for sinusitis treatment are anticipated to increase the number of facilities and services. Key service players are focused on adopting new strategies & policies, increasing point of sales & service agreements, and promoting research & development collaborations across academia and research institutes. Furthermore, continuous new service lunches, joint ventures, partnerships, and mergers & acquisitions are expected to boost the growth of the sinusitis treatment market.
Request Methodology of this report @ https://www.xploremr.com/connectus/request-methodology/4007
Global Sinusitis Treatment Market: Additional Questions Answered
Some of the additional questions addressed in this report on the global sinusitis treatment market are as follows:
- What is the revenue potential of the sinusitis treatment market across North America, Europe, and East Asia?
- Who are the key competitors and what are their portfolios in sinusitis treatment market?
- What are the major challenges influencing the growth of the sinusitis treatment market?
- How is intervention from regulatory authorities shaping the growth of the sinusitis treatment market?
About us:
XploreMR is one of the world’s leading resellers of high-quality market research reports. We feature in-depth reports from some of the world’s most reputed market research companies and international organizations. We serve across a broad spectrum – from Fortune 500 to small and medium businesses. Our clients trust us for our unwavering focus onquality and affordability. We believe high price should not be a bottleneck for organizations looking to gain access to quality information.
Our team comprises an eclectic mix of experienced market research specialists, search engine specialists, web designers, online marketers, and business writers. The team is highly committed to going above and beyond, and serving the research needs of our clientele.
Contact us:
111 North Market Street, Suite 300,
San Jose, CA 95113, United States
Tel: +1-669-284-0108
E-mail: sales@xploremr.com
Website: www.xploremr.com
No comments:
Post a Comment